查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888994

美國臍血管導管市場規模、佔有率和趨勢分析報告：按產品、材料、通路、適應症/用途、最終用途和細分市場預測（2025-2033 年）

U.S. Umbilical Vessel Catheters Market Size, Share & Trends Analysis Report By Product (Umbilical Arterial Catheters, Umbilical Venous Catheters), By Material, By Channel, By Indication/Use, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10個工作天內

價格

美國臍血管導管市場摘要

2024年美國臍血管導管市場規模估計為1.6539億美元，預計2033年將達到2.5883億美元。

預計從 2025 年到 2033 年，該行業將以 5.21% 的複合年成長率成長。這一成長是由早產兒和新生兒併發症的增加所推動的，這些併發症需要即時進行血管通路以進行挽救生命的治療。

新生兒加護病房(NICU) 基礎設施投資的不斷增加，以及三級和四級新生兒監護病房的擴建，進一步推動了對該產品的需求。生物相容性材料、防扭結設計以及導管尖端定位精度的提高等技術進步也促進了該產品的應用。此外，臨床上對感染預防和安全新生兒血管通路的日益重視，也支持了先進的臍血管導管 (UVC) 和臍動脈導管 (UAC) 系統的持續使用。

早產發生率的上升是推動美國臍血管導管產業成長的主要因素。早產兒在新生兒加護病房(NICU) 中通常需要即時建立可靠的血管通路，以便進行輸液、給藥和經腸營養。臍血管導管 (UVC 和 UAC) 在維持這些嬰兒生命早期關鍵階段的生命方面發揮著至關重要的作用。隨著全球早產率的上升和存活率的提高，對先進、安全且抗感染導管的需求持續成長。此外，意識提升和新生兒護理基礎設施的擴張也進一步推動了全球市場的成長。根據《生殖健康日誌》報道，2020年全球早產兒數量仍居高不下，估計為1,340萬人。美國疾病管制與預防中心（CDC）報告稱，2020年至2021年，早期和晚期早產的發生率均上升了4%，但2021年至2022年下降了1-2%。

對先進新生兒加護治療的需求日益成長，是美國臍血管導管產業發展的主要促進因素。隨著早產兒和低出生體重兒數量的持續增加，對可靠、安全的血管通路解決方案的需求也顯著增加。臍血管導管在輸送必需藥物、液體和營養方面發揮至關重要的作用，同時也能對嚴重新生兒進行持續監測。新生兒加護病房（NICU）的擴建和先進醫療技術的應用進一步推動了其使用。此外，提高新生兒存活率和減少併發症的日益重視，也加速了全球醫院對高性能、抗感染導管的採用。

三級和四級新生兒加護病房的擴建也推動了美國臍血管導管產業的成長。這些先進的醫療機構收治了大量需要緊急血管通路的早產兒和嚴重新生兒。隨著越來越多的醫院提升新生兒加護病房（NICU）的水平，對可靠的臍血管導管（UVC）和臍動脈導管（UAC）的需求日益成長，以支持諸如液體復甦、經腸營養、藥物輸注和持續監測等救生操作。這些機構嚴格遵循臨床通訊協定，並規範臍導管的使用，以確保其使用一致性。隨著對專業新生兒護理基礎設施投資的不斷增加，高品質導管對於提供先進的新生兒護理變得愈發重要。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章美國臍血管導管市場變數、趨勢與範圍

  • 市場譜系展望
    • 相關市場展望
  • 市場動態
  • 美國臍血管導管市場分析工具
    • 波特分析
    • PESTEL 分析

第4章美國臍血管導管市場：按產品分類的估算與趨勢分析

  • 美國臍血管導管市場產品變化分析
  • 美國臍血管導管市場規模及趨勢分析（依產品分類，2021-2033 年）
  • 臍動脈導管（UAC）
  • 臍靜脈導管（UVC）

第5章美國臍血管導管市場：依材料分類的估算與趨勢分析

  • 美國臍血管導管市場材料差異分析
  • 美國臍血管導管市場規模及趨勢分析（依材料分類，2021-2033 年）
  • 聚氨酯導管
  • 矽膠導管
  • PVC塗層導管
  • 其他

第6章：美國臍血管導管市場：按通路的估算和趨勢分析

  • 依分銷管道分析美國臍血管導管市場通路
  • 美國臍血管導管市場規模及趨勢分析（依通路分類）（2021-2033 年）
  • 單腔
  • 雙腔
  • 三流明

第7章 臍血管導管市場：依適應症/應用分類的估算與趨勢分析

  • 美國臍血管導管市場：按適應症/應用分類的差異分析
  • 美國臍血管導管市場規模及趨勢分析（依適應症/應用分類，2021-2033 年）
  • 新生兒靜脈通路困難（DVA）的緊急復甦
  • 換血療法
  • 心臟導管插入術
  • 腸外營養
  • 藥物管理
  • 頻繁的血液採樣/動脈血氣監測

第8章美國臍血管導管市場：按最終用途分類的估算和趨勢分析

  • 美國臍血管導管市場按最終用途分類的差異分析
  • 美國臍血管導管市場規模及趨勢分析（依最終用途分類，2021-2033年）
  • 醫院（新生兒加護病房）
  • 專科診所或中心
  • 門診手術中心

第9章 競爭情勢

  • 市場參與企業分類
  • 主要企業簡介
    • Vygon
    • Utah Medical Products, Inc.
    • Cardinal Health
    • Laborie
    • AMECATH
    • Neotech Products
  • 2024年企業市場占有率分析
  • 其他主要市場公司名單
Product Code: GVR-4-68040-822-9

U.S. Umbilical Vessel Catheters Market Summary

The U.S. umbilical vessel catheters market size was estimated at USD 165.39 million in 2024 and is projected to reach USD 258.83 million by 2033, growing at a CAGR of 5.21% from 2025 to 2033. This growth is attributed to the rising prevalence of preterm births and neonatal complications that require immediate vascular access for life-saving interventions.

Growing investments in NICU infrastructure, coupled with the expansion of Level III and Level IV neonatal care units, further strengthen demand for the product. Technological improvements, such as biocompatible materials, kink-resistant designs, and enhanced catheter tip positioning, also enhance adoption. Furthermore, heightened clinical emphasis on infection prevention and safe neonatal vascular access supports the continued use of advanced UVC and UAC systems.

The rising incidence of preterm births is a primary factor driving the growth of the U.S. umbilical vessel catheters industry. Preterm infants often require immediate and reliable vascular access for administering fluids, medications, and parenteral nutrition in neonatal intensive care units (NICUs). Umbilical vessel catheters (UVCs and UACs) play a crucial role in stabilizing these infants during the critical early stages of life. With increasing global preterm birth rates and improved survival outcomes, the demand for advanced, safe, and infection-resistant catheters continues to rise. Moreover, growing awareness among healthcare professionals and the expansion of neonatal care infrastructure further support market growth worldwide. According to the Reproductive Health Journal, the number of preterm births remained high globally, with an estimated 13.4 million cases in 2020. According to the Centers for Disease Control and Prevention (CDC), both early and late preterm birth rates increased by 4% from 2020 to 2021 but later declined by 1%-2% from 2021 to 2022.

The growing need for advanced neonatal intensive care is a major factor driving the U.S. umbilical vessel catheters industry. As the number of preterm and low-birth-weight infants continues to rise, the demand for reliable and safe vascular access solutions has increased significantly. Umbilical vessel catheters play a crucial role in delivering essential medications, fluids, and nutrition while allowing continuous monitoring of critically ill newborns. The expansion of neonatal intensive care units (NICUs) and the adoption of advanced medical technologies are further enhancing their use. In addition, the focus on improving neonatal survival rates and reducing complications is accelerating the adoption of high-performance, infection-resistant catheters across hospitals worldwide.

The expansion of Level III and Level IV neonatal care units is another driver of the U.S. umbilical vessel catheter industry, as these advanced facilities manage the highest volume of premature and critically ill newborns requiring immediate vascular access. As more hospitals upgrade their NICU capabilities, the demand for reliable UVCs and UACs increases to support life-saving interventions, including fluid resuscitation, parenteral nutrition, medication delivery, and continuous monitoring. These units follow stringent clinical protocols that standardize the use of umbilical catheters, ensuring consistent utilization. As investment in specialized neonatal infrastructure increases, the need for high-quality catheters becomes even more crucial in delivering advanced newborn care.

U.S. Umbilical Vessel Catheters Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. umbilical vessel catheters market report based on product, material, channel, indication/use and end use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Umbilical Arterial Catheters (UACs)
  • Umbilical Venous Catheters (UVCs)
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Polyurethane-based Catheters
  • Silicone-based Catheters
  • PVC-coated Catheters
  • Others
  • Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Single Lumen
  • Double Lumen
  • Triple Lumen
  • Indication/Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation
  • Exchange Blood Transfusion
  • Cardiac Catheterisation
  • Parenteral Nutrition
  • Drug Administration
  • Frequent Blood Sampling/Arterial Blood Gas Monitoring
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals (NICUs)
  • Specialty Clinics or Centers
  • Ambulatory Surgery Centers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Material
    • 1.2.3. Channel
    • 1.2.4. Indication/Use
    • 1.2.5. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
    • 1.5.5. Information Analysis
  • 1.6. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Umbilical Vessel Catheters Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising preterm births and neonatal complications
      • 3.2.1.2. Expansion of level III and level IV NICUs
      • 3.2.1.3. Growing focus on neonatal survival and early intervention
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk of catheter-related complications
      • 3.2.2.2. Strict regulatory requirements
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Growing NICU infrastructure investments
      • 3.2.3.2. Technological advancements
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Maintaining high safety standards
      • 3.2.4.2. Short window of use
  • 3.3. U.S. Umbilical Vessel Catheters Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Umbilical Vessel Catheters Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Umbilical Vessel Catheters Market Product Movement Analysis
  • 4.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Umbilical Arterial Catheters (UACs)
    • 4.4.1. Umbilical Arterial Catheters (UACs) U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Umbilical Venous Catheters (UVCs)
    • 4.5.1. Umbilical Venous Catheters (UVCs) U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Umbilical Vessel Catheters Market: Material Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Umbilical Vessel Catheters Market Material Movement Analysis
  • 5.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
  • 5.4. Polyurethane-based Catheters
    • 5.4.1. Polyurethane-based Catheters U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Silicone-based Catheters
    • 5.5.1. Silicone-based Catheters U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. PVC-coated Catheters
    • 5.6.1. PVC-coated Catheters U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Umbilical Vessel Catheters Market: Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Umbilical Vessel Catheters Market Channel Movement Analysis
  • 6.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by Channel, 2021 to 2033 (USD Million)
  • 6.4. Single Lumen
    • 6.4.1. Single Lumen U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Double Lumen
    • 6.5.1. Double Lumen U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Triple Lumen
    • 6.6.1. Triple Lumen U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Umbilical Vessel Catheters Market: Indication/Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Umbilical Vessel Catheters Market Indication/Use Movement Analysis
  • 7.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by Indication/Use, 2021 to 2033 (USD Million)
  • 7.4. Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation
    • 7.4.1. Neonates with difficult venous access (DVA) for emergency resuscitation market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.5. Exchange Blood Transfusion
    • 7.5.1. Exchange blood transfusion market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.6. Cardiac Catheterisation
    • 7.6.1. Cardiac catheterisation market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.7. Parenteral Nutrition
    • 7.7.1. Parenteral nutrition market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.8. Drug Administration
    • 7.8.1. Drug administration market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.9. Frequent blood sampling/arterial blood gas monitoring
    • 7.9.1. Frequent blood sampling/arterial blood gas monitoring market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 8. U.S. Umbilical Vessel Catheters Market: End-Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Umbilical Vessel Catheters Market End-Use Movement Analysis
  • 8.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by End-Use, 2021 to 2033 (USD Million)
  • 8.4. Hospitals (NICUs)
    • 8.4.1. Hospitals (NICUs) U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Specialty Clinics or Centers
    • 8.5.1. Specialty Clinics or Centers U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Ambulatory Surgery Centers
    • 8.6.1. Ambulatory Surgery Centers U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Vygon
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Material Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Utah Medical Products, Inc.
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Material Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Cardinal Health
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Material Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Laborie
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Material Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. AMECATH
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Material Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. Neotech Products
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Material Benchmarking
      • 9.2.6.4. Strategic Initiatives
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. List of Other Key Market Players

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Umbilical Vessel Catheters Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 U.S. Umbilical Vessel Catheters Market, by Material, 2021 - 2033 (USD Million)
  • Table 5 U.S. Umbilical Vessel Catheters Market, by Channel, 2021 - 2033 (USD Million)
  • Table 6 U.S. Umbilical Vessel Catheters Market, by Indications/Use, 2021 - 2033 (USD Million)
  • Table 7 U.S. Umbilical Vessel Catheters Market, by End-Use, 2021 - 2033 (USD Million)
  • Table 8 Participant's Overview
  • Table 9 Financial Performance
  • Table 10 Material Benchmarking
  • Table 11 Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Umbilical Vessel Catheters Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Regional Marketplace: Key Takeaways
  • Fig. 13 U.S. Umbilical Vessel Catheters Market, for Product, 2021 - 2033 (USD Million)
  • Fig. 14 U.S. Umbilical Vessel Catheters Market, for Umbilical Arterial Catheters (UACs), 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Umbilical Vessel Catheters Market, for Umbilical Venous Catheters (UVCs), 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Umbilical Vessel Catheters Market, for Material, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Umbilical Vessel Catheters Market, for Polyurethane-based Catheters, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Umbilical Vessel Catheters Market, for Silicone-based Catheters, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Umbilical Vessel Catheters Market, for PVC-coated Catheters, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Umbilical Vessel Catheters Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Umbilical Vessel Catheters Market, for Channel, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Umbilical Vessel Catheters Market, for Single Lumen, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Umbilical Vessel Catheters Market, for Double Lumen, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. Umbilical Vessel Catheters Market, for Triple Lumen, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Umbilical Vessel Catheters Market, for Indication/Use, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. Umbilical Vessel Catheters Market, for Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. Umbilical Vessel Catheters Market, for Exchange Blood Transfusion, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Umbilical Vessel Catheters Market, for Cardiac Catheterisation, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Umbilical Vessel Catheters Market, for Drug Administration, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. Umbilical Vessel Catheters Market, for Frequent Blood Sampling/Arterial Blood Gas Monitoring, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Umbilical Vessel Catheters Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Umbilical Vessel Catheters Market, for Hospitals (NICUs), 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Umbilical Vessel Catheters Market, for Specialty Clinics or Centers, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. Umbilical Vessel Catheters Market, for Ambulatory Surgery Centers, 2021 - 2033 (USD Million)